Skip to content

Brain Activity During Gait in Parkinson's

Brain Activity Response to Cues During Gait in Parkinson's

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04863560
Acronym
BARC-PD
Enrollment
80
Registered
2021-04-28
Start date
2020-10-01
Completion date
2022-11-30
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkison's disease, Gait, functional near infrared spectroscopy, electroencephalography, Inertial Sensors, Brain activity, Cueing

Brief summary

Lay Summary: Walking problems, such as slow and short steps, are very common in Parkinson's disease and lead to increased falls risk, as well as reduced mobility and quality of life. Walking issues are difficult to treat as medication interventions do not restore walking ability in people with Parkinson's, therefore physiotherapy approaches are used to help improve walking. Various physiotherapy strategies have been used, such as internal (thinking about bigger steps) or external prompts. External prompts include auditory (a metronome beat to step in time to), visual (lines to step over on the floor) and tactile (metronome-like vibration to step with) prompts that are very commonly used to improve walking in Parkinson's. However, the reason why walking improves in people with Parkinson's with these physiotherapy strategies is unknown, which has led to not all patients benefiting and only short-term walking improvements being seen. The main issues are that it is unclear if these various internal or external prompt strategies are effective with the progression of Parkinson's disease, and it is unknown which type of strategy is most effective at different disease stages or with more severe walking impairment, such as freezing (the inability to progress walking for short periods despite wanting to do so). Being able to use specific brain regions to pay attention to different internal or external prompts has been suggested to be the reason why people with Parkinson's can overcome their walking problems, but this has not been tested. Therefore, this study will use state-of-the-art digital technology to measure walking and brain activity changes with different internal and external prompts. The investigators think that the walking improvement with different prompt strategies relies on the ability to activate specific brain regions, and that brain region activity in response to internal or external prompts will change at different stages of Parkinson's disease. Ultimately, understanding the reasons why people benefit from these physiotherapy strategies and who benefits most from specific strategies will enable clinicians to provide more timely and efficient treatment for people with Parkinson's, and to develop more effective strategies to further improve walking.

Interventions

Metronome beat to step in time with

Lines on the floor to step over

OTHERtactile Cueing

Vibration to step in time with (metronome like)

Sponsors

Parkinson's Foundation
CollaboratorOTHER
Northumbria Healthcare NHS Foundation Trust
CollaboratorOTHER
Northumbria University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson's by a movement disorder specialist according to United Kingdom (UK) brain bank criteria * Hoehn & Yahr (H&Y) stage I-III * Aged \>50 years * Able to walk and stand unaided * Adequate hearing (as evaluated by the whisper test; stand 2m behind subject and whisper a 2 syllable word, subject repeats word) and vision capabilities (as measured using a Snellen chart - 6/18-6/12). * Stable medication for the past 1 month and anticipated over a period of 6 months

Exclusion criteria

* Psychiatric co-morbidity (e.g., major depressive disorder as determined by Geriatric Depression Scale - short form (GDS-15); \<10 \[26\]) * Clinical diagnosis of dementia or other severe cognitive impairment (Montreal cognitive assessment \<21 \[27\]) * History of stroke, traumatic brain injury or other neurological disorders (other than PD, for the PD group) * Acute lower back or lower extremity pain, peripheral neuropathy, rheumatic and orthopaedic diseases * Unstable medical condition including cardio-vascular instability in the past 6 months * Unable to comply with the testing protocol or currently participating in another interfering research project * Interfering therapy

Design outcomes

Primary

MeasureTime frameDescription
Change in cortical oxygenated hemoglobin (HbO2) signal during walkingimmediately after interventionChange in cortical oxygenated hemoglobin (HbO2) measured while walking with cueing, which will be quantified with a wireless functional near infrared spectroscopy (fNIRS) system
Change in cortical power spectral densities during walkingimmediately after interventionChange in cortical power spectral densities of EEG signals from cortex with cueing, which will be quantified with a mobile electroencephalography (EEG) system

Secondary

MeasureTime frameDescription
Change in Stride Length (m)immediately after interventionChange in stride length with cueing
Change in Gait Speed (m/s)immediately after interventionChange in speed of walking with cueing
Change in Stride Time (s)immediately after interventionChange in time taken to complete a stride when walking with cues
Change in Gait Variability (SD)immediately after interventionChange in variability (standard deviation; SD) of gait when walking with cues

Countries

United Kingdom, United States

Contacts

Primary ContactSamuel Stuart, PhD
sam.stuart@northumbria.ac.uk01912233343

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026